Shop + dossier
CJC-1295 (no DAC), GHRP-2 10mg (Blend)
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Category page
Peptide Blends
All 21 research compounds in the peptide blends category, with links to detailed product dossiers and molecule data.
Products
Peptide Blends compounds
All 21 research compounds in this category with links to product dossiers and data.
Dossier
BPC-157, TB-500 (Blend)
The combination of BPC-157 and TB-500 combines two well-characterized research peptides that have been studied with respect to their roles in cellular repair, angiogenesis, and tissue remodeling.
Dossier
BPC-157, TB-500, GHK-Cu (Glow Blend)
The Glow Blend combines three research peptides, BPC-157, TB-500, and GHK-Cu, formulated for studies on cellular repair, angiogenesis, and regulation of the extracellular matrix.
Dossier
BPC-157, TB-500, KPV, GHK-Cu 80mg (Klow Blend)
The Klow Blend combines four research peptides, BPC-157, TB-500, KPV, and GHK-Cu, that are formulated for studies on cellular repair, immunomodulation, and regulation of the extracellular matrix.
Dossier
CJC-1295 (no DAC), GHRP-2 10mg (Blend)
CJC-1295 (no DAC) and GHRP-2 is a research peptide mixture designed to investigate the synergistic stimulation of the growth hormone axis through two receptor pathways.
Dossier
CJC-1295 (no DAC), GHRP-6 10mg (Blend)
CJC-1295 (without DAC) and GHRP-6 is a research peptide mixture that combines GHRH and ghrelin receptor agonists to produce a synergistic stimulation of the GH axis.
Dossier
CJC-1295 (no DAC), Hexarelin 10mg (Blend)
CJC-1295 (without DAC) and Hexarelin are a research peptide mixture that combines GHRH receptor and ghrelin receptor agonists to model growth hormone signaling.
Dossier
CJC-1295 (no DAC), Ipamorelin 10mg (Blend)
CJC-1295 (without DAC) and Ipamorelin are a research peptide mixture that combines two mechanistically distinct secretagogues that act synergistically on the growth hormone axis.
Dossier
CJC-1295 (no DAC), Ipamorelin, GHRP-2 (Blend)
CJC-1295 (without DAC), Ipamorelin and GHRP-2 is a research peptide mixture that has been formulated to investigate synergistic mechanisms of growth hormone release through dual receptor activation.
Dossier
Fragment, CJC-1295 (no DAC), Ipamorelin 12mg (Blend)
Fragment, CJC-1295 (without DAC) and Ipamorelin are a research peptide mixture that combines the hGH fragment 176–191 with GHRH- and ghrelin receptor agonists to enable coordinated modeling of the growth hormone axis.
Dossier
Mod GRF, GHRP-2 10mg (Blend)
Mod GRF and GHRP-2 is a research peptide mixture that combines GHRH and ghrelin receptor agonists for the experimental modeling of the GH axis.
Dossier
Mod GRF, GHRP-6 10mg (Blend)
Mod GRF and GHRP-6 is a research peptide mixture that combines activation of the GHRH receptor and the ghrelin receptor to model the secretion of growth hormone.
Dossier
Mod GRF, Hexarelin 10mg (Blend)
Mod GRF and Hexarelin is a research peptide mixture that integrates the activation of the GHRH receptor and the signaling of the ghrelin receptor to investigate GH release mechanisms.
Dossier
Mod GRF, Ipamorelin 10mg (Blend)
Modified GRF 5 mg, Ipamorelin 5 mg (10 mg total mixture)
Dossier
Mod GRF, Ipamorelin, GHRP-2 (Blend)
Mod GRF, Ipamorelin and GHRP-2 is a research peptide mixture aimed at investigating the synergistic regulation of growth hormone secretion via multiple receptor pathways.
Dossier
Sermorelin, GHRP-2 10mg (Blend)
Sermorelin and GHRP-2 form a research peptide blend designed to investigate a synergistic modulation of growth hormone secretion through complementary receptor pathways.
Dossier
Sermorelin, GHRP-6 10mg (Blend)
Sermorelin and GHRP-6 is a research peptide mixture that aims to investigate the cooperative activation of the GHRH- and ghrelin-receptor signaling pathways in pituitary models.
Dossier
Sermorelin, GHRP-6, GHRP-2 9mg (Blend)
Sermorelin, GHRP-6 and GHRP-2 are a research peptide mixture that combines three different growth hormone secretagogues that act synergistically on the hypothalamic-pituitary axis.
Dossier
Sermorelin, Ipamorelin 10mg (Blend)
Sermorelin and Ipamorelin are a research peptide mixture that combines a GHRH analog with a ghrelin receptor agonist to study the regulation of growth hormone.
Dossier
Tesamorelin, CJC-1295 (no DAC), Ipamorelin 12mg (Blend)
Tesamorelin, CJC-1295 (without DAC) and Ipamorelin are a research peptide mixture formulated to investigate modulation of the growth hormone axis through combined GHRH- and ghrelin-receptor pathways.
Dossier
Tesamorelin, Ipamorelin 8mg (Blend)
Tesamorelin and Ipamorelin form a research peptide mixture aimed at exploring a synergistic activation of the growth hormone axis through two receptor mechanisms.
Explore
Related categories
Browse other research compound categories.